Resources

Dr. Steven Edelman talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the importance of food control along with exercise.

I have type 1 diabetes and have been living with it for the past 11 years. I take daily insulin injections to stay alive and well. A couple of years ago, I had a very frustrating incident when my insulin stopped working. I began injecting loads of insulin, and even with multiple doses my blood glucose wouldn’t drop.

Dr. Hartman discusses diabetes, hyperlipidemia and obesity, and why it is crucial to treat obesity as a clinical condition, not a willpower issue.

In this Exclusive Interview, Dr. Hartman discuss practical points in the approach of the patient with diabetes, hyperlipidemia and obesity.

In this week's Homerun Slides, the initiation of basal insulin.

Intravenous glucose: In the presence of euglycemia, insulin displays a potent suppressive action on hepatic glucose production, such that portal insulin concentrations of less than 100 mU L−1 abolish glucose entry into the circulation. Figure 14.7 shows a typical time course for endogenous glucose production following an acute increase in plasma insulin to levels of 60 – 70 mU L−1 in a healthy subject.

Medical pioneer has educated his diabetes patients on how to get blood sugars to 83mg/dl, 24 hours a day

The Endocrinologic and Metabolic Drugs Advisory Committee also voted 19-0 that the drug's use in type 2 diabetes patients did not result in excess cardiovascular risk.

Research will still continue due to its safety.

However, in 2016, Novo Nordisk halted the development of their basal oral insulin tablet.